These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 30632835)

  • 81. Richter transformation in Chronic Lymphocytic Leukemia.
    Innocenti I; Benintende G; Tomasso A; Fresa A; Autore F; Larocca LM; Laurenti L
    Hematol Oncol; 2023 Aug; 41(3):293-300. PubMed ID: 36433773
    [TBL] [Abstract][Full Text] [Related]  

  • 82. An update for Richter syndrome - new directions and developments.
    Eyre TA; Schuh A
    Br J Haematol; 2017 Aug; 178(4):508-520. PubMed ID: 28439883
    [TBL] [Abstract][Full Text] [Related]  

  • 83. An Approach to Diagnosis of Richter Transformation in Chronic Lymphocytic Leukemia.
    Broadway-Duren J
    J Adv Pract Oncol; 2022 Jul; 13(5):535-538. PubMed ID: 35910501
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Chronic lymphocytic leukemia with paraimmunoblastic transformation - with comparative genomic hybridization and review of the literature.
    Chuang SS; Liao YL; Liou CP; Wiggins ML; Ye H; Du MQ; Isaacson PG; Chang CC
    Pathol Res Pract; 2010 Apr; 206(4):276-81. PubMed ID: 19433347
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Comprehensive Analysis of Disease-Related Genes in Chronic Lymphocytic Leukemia by Multiplex PCR-Based Next Generation Sequencing.
    Vollbrecht C; Mairinger FD; Koitzsch U; Peifer M; Koenig K; Heukamp LC; Crispatzu G; Wilden L; Kreuzer KA; Hallek M; Odenthal M; Herling CD; Buettner R
    PLoS One; 2015; 10(6):e0129544. PubMed ID: 26053404
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Risk factors associated with Richter's transformation in patients with chronic lymphocytic leukaemia: protocol for a retrospective population-based cohort study.
    Hleuhel MH; Ben-Dali Y; Da Cunha-Bang C; Brieghel C; Clasen-Linde E; Niemann CU; Andersen MA
    BMJ Open; 2019 Mar; 9(3):e023566. PubMed ID: 30833314
    [TBL] [Abstract][Full Text] [Related]  

  • 87. miR-31 and miR-17-5p levels change during transformation of follicular lymphoma.
    Thompson MA; Edmonds MD; Liang S; McClintock-Treep S; Wang X; Li S; Eischen CM
    Hum Pathol; 2016 Apr; 50():118-26. PubMed ID: 26997445
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Cytogenomic features of Richter transformation.
    Woroniecka R; Rymkiewicz G; Bystydzienski Z; Pienkowska-Grela B; Rygier J; Malawska N; Wojtkowska K; Goral N; Blachnio K; Chmielewski M; Bartnik-Glaska M; Grygalewicz B
    Mol Cytogenet; 2023 Nov; 16(1):31. PubMed ID: 37941034
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Hodgkin's variant of Richter transformation in chronic lymphocytic leukemia; a retrospective study from the Israeli CLL study group.
    Tadmor T; Shvidel L; Goldschmidt N; Ruchlemer R; Fineman R; Bairey O; Rahimi-Levene N; Herishanu Y; Yuklea M; Arad A; Aviv A; Polliack A
    Anticancer Res; 2014 Feb; 34(2):785-90. PubMed ID: 24511013
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Risk factors for Richter syndrome in chronic lymphocytic leukemia.
    Parikh SA; Shanafelt TD
    Curr Hematol Malig Rep; 2014 Sep; 9(3):294-9. PubMed ID: 25218362
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Richter syndrome: molecular insights and clinical perspectives.
    Rossi D; Gaidano G
    Hematol Oncol; 2009 Mar; 27(1):1-10. PubMed ID: 19206112
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Alternate clonal dominance in richter transformation presenting as extranodal diffuse large B-cell lymphoma and synchronous classic Hodgkin lymphoma.
    Di Bernardo A; Mussetti A; Aiello A; De Paoli E; Cabras AD
    Am J Clin Pathol; 2014 Aug; 142(2):227-32. PubMed ID: 25015865
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Hodgkin's disease variant of Richter's syndrome clonally related to chronic lymphocytic leukemia arises in ZAP-70 negative mutated CLL.
    Tzankov A; Fong D
    Med Hypotheses; 2006; 66(3):577-9. PubMed ID: 16223567
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [The genetic landscape of chronic lymphocytic leukemia].
    Marosvári D; Alpár D; Király AP; Rajnai H; Reiniger L; Bödör C
    Magy Onkol; 2016 Jun; 60(2):118-25. PubMed ID: 27275638
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Treatment of Richter's Syndrome.
    Condoluci A; Rossi D
    Curr Treat Options Oncol; 2017 Nov; 18(12):75. PubMed ID: 29159711
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Herpes simplex infection simulating Richter transformation: a series of four cases and review of the literature.
    Salem A; Loghavi S; Khoury JD; Agbay RL; Jorgensen JL; Medeiros LJ
    Histopathology; 2017 Apr; 70(5):821-831. PubMed ID: 27905140
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Distinct immune-response profile of Richter transformation chronic lymphocytic leukemia (CLL), defined by high expression of PD1, LAG3, TIM3 and IL-10.
    Behdad A; Schipma MJ; Ma S; Chen YH; Chen QC
    Leuk Lymphoma; 2022 Dec; 63(13):3222-3226. PubMed ID: 36102789
    [No Abstract]   [Full Text] [Related]  

  • 98. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
    Matolcsy A; Chadburn A; Knowles DM
    Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Artificial intelligence-assisted mapping of proliferation centers allows the distinction of accelerated phase from large cell transformation in chronic lymphocytic leukemia.
    El Hussein S; Chen P; Medeiros LJ; Hazle JD; Wu J; Khoury JD
    Mod Pathol; 2022 Aug; 35(8):1121-1125. PubMed ID: 35132162
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The complex interplay between cell-intrinsic and cell-extrinsic factors driving the evolution of chronic lymphocytic leukemia.
    Sutton LA; Rosenquist R
    Semin Cancer Biol; 2015 Oct; 34():22-35. PubMed ID: 25963298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.